Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
RELIEF THERAPEUTICS Holding (RLFTF)
OTHER OTC:RLFTF
Holding RLFTF?
Track your performance easily
RLFTF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.10 - $7.66
Previous Close$6.94
Volume1.73K
Average Volume (3M)4.26K
Market Cap
$86.15M
Enterprise Value$72.50M
Total Cash (Recent Filing)CHF14.56M
Total Debt (Recent Filing)CHF2.43M
Price to Earnings (P/E)―
Beta-0.69
Next Earnings
Mar 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.16
Shares Outstanding12,540,439
10 Day Avg. Volume6,584
30 Day Avg. Volume4,256
Standard Deviation0.37
R-Squared0.02
Alpha-0.00115
Financial Highlights & Ratios
Price to Book (P/B)1.67
Price to Sales (P/S)13.10
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
RLFTF FAQ
What was RELIEF THERAPEUTICS Holding’s price range in the past 12 months?
RELIEF THERAPEUTICS Holding lowest stock price was $1.10 and its highest was $7.66 in the past 12 months.
What is RELIEF THERAPEUTICS Holding’s market cap?
Currently, no data Available
When is RELIEF THERAPEUTICS Holding’s upcoming earnings report date?
RELIEF THERAPEUTICS Holding’s upcoming earnings report date is Mar 28, 2025 which is in 127 days.
How were RELIEF THERAPEUTICS Holding’s earnings last quarter?
RELIEF THERAPEUTICS Holding released its earnings results on Aug 30, 2024. The company reported -$0.409 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.409.
Is RELIEF THERAPEUTICS Holding overvalued?
According to Wall Street analysts RELIEF THERAPEUTICS Holding’s price is currently Overvalued.
Does RELIEF THERAPEUTICS Holding pay dividends?
RELIEF THERAPEUTICS Holding does not currently pay dividends.
What is RELIEF THERAPEUTICS Holding’s EPS estimate?
RELIEF THERAPEUTICS Holding’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RELIEF THERAPEUTICS Holding have?
RELIEF THERAPEUTICS Holding has 14,040,837 shares outstanding.
What happened to RELIEF THERAPEUTICS Holding’s price movement after its last earnings report?
RELIEF THERAPEUTICS Holding reported an EPS of -$0.409 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.349%.
Which hedge fund is a major shareholder of RELIEF THERAPEUTICS Holding?
Currently, no hedge funds are holding shares in RLFTF
---
RELIEF THERAPEUTICS Holding Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
230.47%
12-Months-Change
Fundamentals
Return on Equity
-65.13%
Trailing 12-Months
Asset Growth
-43.86%
Trailing 12-Months
Company Description
RELIEF THERAPEUTICS Holding
Relief Therapeutics Holding AG is a Switzerland based drug development company focusing on clinical stage projects, primarily developing drugs of natural human origin. It is engaged in its operations for diabetic complications and respiratory diseases. The company is focused on developing drug candidates namely, Aviptadil and Atexakin alfa. Aviptadil is a biologically active endogenous human peptide that possesses anti-proliferative, anti-inflammatory, and immune regulatory activities. Atexakin alfa is a low dosage formulation of interleukin-6 that exhibits functions in diverse tissues and organs. The group operates its functions in Switzerland.
---
Technical Analysis
---